Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 10 of 14, showing 5 Applications out of 67 total, starting on record 46, ending on 50

# Protocol No Study Title Investigator(s) & Site(s)

46.

ECCT/23/02/04   mRNA-1273-P203
    A Phase 2/3, Randomized, Observer-Blind, Placebo‑Controlled Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA‑1273 SARS‑CoV‑2 Vaccine in Healthy Adolescents 12 to <18 Years of Age   
Principal Investigator(s)
1. Dr Victor Mudhune
Site(s) in Kenya
1. Victoria Biomedical Research Institute (Kisumu county)
2. KEMRI/USAMRD (Kericho county)
3. Kenya Medical Research Institute/USAMRU (Kisumu county)
4. KEMRI CMR-Kar Geno Research Centre (Kisumu county)
5. KEMRI CMR-Kar Geno Research Centre (Kisumu county)
6. KEMRI CRDR - Clinical Research Nairobi (Nairobi City county)
7. KEMRI/ CDC (Kisumu county)
8. KEMRI (Kisumu county)
9. KEMRI Centre for Clinical Research Butere County Hospital (Kakamega county)
10. KAVI Institute of Clinical Reasearch, College of Health science (Nairobi City county)
 
View

47.

ECCT/23/05/05   mRNA-1273-P203
    A Phase 2/3, Randomized, Observer-Blind, Placebo‑Controlled Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA‑1273 SARS‑CoV‑2 Vaccine in Healthy Adolescents 12 to <18 Years of Age   
Principal Investigator(s)
1. Videlis Nduba
Site(s) in Kenya
1. KEMRI CRDR - Clinical Research Nairobi (Nairobi City county)
2. KEMRI/USAMRD (Kericho county)
3. Victoria Biomedical Research Institute (Kisumu county)
4. Kenya Medical Research Institute/USAMRU (Kisumu county)
5. KEMRI CMR-Kar Geno Research Centre (Kisumu county)
6. KEMRI/ CDC (Kisumu county)
7. KEMRI (Kisumu county)
8. KEMRI Centre for Clinical Research Butere County Hospital (Kakamega county)
9. KAVI Institute of Clinical Reasearch, College of Health science (Nairobi City county)
 
View

48.

ECCT/23/04/01   mRNA-1273-P203
    A Phase 2/3, Randomized, Observer-Blind, Placebo‑Controlled Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA‑1273 SARS‑CoV‑2 Vaccine in Healthy Adolescents 12 to <18 Years of Age   
Principal Investigator(s)
1. Dr Janet Oyieko
Site(s) in Kenya
1. KEMRI Centre for Clinical Research Butere County Hospital (Kakamega county)
2. KEMRI CRDR - Clinical Research Nairobi (Nairobi City county)
3. KEMRI/USAMRD (Kericho county)
4. Victoria Biomedical Research Institute (Kisumu county)
5. Kenya Medical Research Institute/USAMRU (Kisumu county)
6. KEMRI CMR-Kar Geno Research Centre (Kisumu county)
7. KEMRI/ CDC (Kisumu county)
8. KEMRI (Kisumu county)
9. KAVI Institute of Clinical Reasearch, College of Health science (Nairobi City county)
 
View

49.

ECCT/23/09/03   CONSTELLATION
    A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the effect of Bi-26 (strain of Bifidobacterium longum, B. infantis) supplementation versus placebo on weight gain in underweight infants   
Principal Investigator(s)
1. Dr Simon Kariuki
Site(s) in Kenya
1. Kenya Medical Research Institute- Centre for Global Health Research (Kisumu county)
 
View

50.

ECCT/19/12/02   VPM1002 Phase III PoI
    A multicenter, Phase III double blind, randomized active controlled study to evaluate efficacy and safety of VPM1002 in comparison with BCG in prevention of Mycobacterium tuberculosis infection in newborn infants.     
Principal Investigator(s)
1. Videlis Nduba
Site(s) in Kenya
1. KEMRI-CRDR Nairobi (Nairobi City county)
2. KEMRI-CRDR Siaya (Siaya county)
 
View